Apply acoustic cell processing to industrialize cell therapy manufacturing thus helping to reduce cost and improve patient accessibility
Our Vision
A modernized cell therapy process with closed, automated and integrated systems for each step based on FloDesign Sonics’ acoustic engine in both off the shelf formats as well as bespoke solutions
2012
NSF Phase I SBIR AWARD
2013
Series A Funding
BioPharm Separations Development Program
NSF Phase II SBIR AWARD
2014
Multiple Biotech Co-Development Agreements Signed
NIH Phase I SBIR AWARD
2015
Pall Corp License Agreement
Cell and Gene Therapy Development Program
2016
NSF Phase IIB AWARD
PALL Launches Acoustic Based CadenceTM System
2017
Expanded Development Program to Explore Concentrate / Wash, Cell Selection and Cell Retention Applications
2018
Launched Beta Demonstration System
Cognate BioServices Collaboration
Significant Investment in FDS Team. Hiring Key Industry Experts
